ARDELYX INC. - COMMON STOCK

Ardelyx, Inc. Reports Employment Inducement Grants

20 ديسمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

19 ديسمبر 2023 08:46:12 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

18 ديسمبر 2023 08:45:08 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

15 ديسمبر 2023 08:45:15 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

14 ديسمبر 2023 08:45:03 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

13 ديسمبر 2023 08:47:25 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

07 ديسمبر 2023 08:45:06 بحسب NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

06 ديسمبر 2023 11:28:31 بحسب NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

21 نوفمبر 2023 15:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference

21 نوفمبر 2023 07:01:45 بحسب Nasdaq GlobeNewswire

XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia

15 نوفمبر 2023 15:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx Announces Departure of Board Member

13 نوفمبر 2023 15:02:00 بحسب Nasdaq GlobeNewswire

Ardelyx to Participate at the Jefferies London Healthcare Conference

10 نوفمبر 2023 07:05:00 بحسب Nasdaq GlobeNewswire

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

06 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance

31 أكتوبر 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 أكتوبر 2023 16:42:57 بحسب Nasdaq GlobeNewswire

Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023

23 أكتوبر 2023 07:07:01 بحسب Nasdaq GlobeNewswire

Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023

18 أكتوبر 2023 15:02:39 بحسب Nasdaq GlobeNewswire

Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital

17 أكتوبر 2023 18:23:38 بحسب Nasdaq GlobeNewswire